logo
logo
Sign in

Insect Cell Expression Technology Is Fastest Growing Segment Fueling The Growth Of Baculovirus Expression System Market

avatar
Ashish Thapa

Market Overview:

Baculovirus expression system uses insect cells for recombinant protein expression. This system offers advantages like high-level production, proper folding and post-translational modifications of recombinant proteins.

Market key trends:

One of the major trends in the market is growing adoption of insect cell expression technology. Baculovirus expression system using insect cells offers advantages over mammalian and bacterial expression systems. Insect cells can process post-translational modifications of proteins similar to mammalian cells. They are also capable of folding complex eukaryotic proteins correctly. Further, insect cells grow rapidly and support high-density cultures for mass production of proteins.


The global Baculovirus Expression System Market Share is estimated to be valued at US$ 368.5 Mn in 2023 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Segment Analysis

The global baculovirus expression system market is dominated by the mammalian expression sub-segment due to increasing R&D investments in biopharmaceuticals. Mammalian expression sub-segment accounted for the largest market share of over 35% in 2022 due to their ability to produce biomolecules with proper post-translational modifications, which helps in developing human therapeutics.

Key Takeaways

The global baculovirus expression system market is expected to witness high growth, exhibiting CAGR of 8.7% over the forecast period, due to increasing R&D investments in biopharmaceuticals.

Regional analysis

North America dominated the global baculovirus expression system market in 2022 and is expected to maintain its dominance over the forecast period. This is attributed to presence of major market players and rising biopharmaceutical industry in the region.

Key players

Key players operating in the baculovirus expression system market are Thermo Fisher Scientific, Merck KGaA, Takara Bio, Agilent Technologies, Oxford Expression Technologies, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, New England Biolabs, Genscript Biotech Corporation, Syngene International Limited, Sartorius AG, Aragen Bioscience, Vivopure, Creative Biogene, Absolute Antibody, Rockland Immunochemicals, Protein Technologies Inc., Proteogenix, Virovek.


Read More: https://www.pressreleasebulletin.com/the-growth-of-the-global-baculovirus-expression-system-market-trend-and-share-analysis/

collect
0
avatar
Ashish Thapa
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more